Rhinocort OTC Expected to be Available Soon
Rhinocort Allergy Spray is anticipated to become available over the counter in the next few months, joining Flonase OTC and Nasacort OTC versions of allergy relief. Rhinocort is indicated for the temporary relief of symptoms of hayfever or other upper respiratory allergies, which include nasal congestion, runny nose, itchy nose and sneezing in adults and children aged 6 years and older. The OTC medicine will provide 32µg budesonide per spray. Rhinocort OTC is manufactured by McNeil Consumer Healthcare, the brand-name version of Rhinocort (budesonide) nasal spray is manufactured by AstraZeneca.
Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval. Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval. Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.
*This is provided for information only. The reference to any medication above does not mean the medication is covered by your plan.